Intelligence · Clinical pipeline
Approved programs Pipeline Programs
ClinicalTrials.gov programs marked approved or launched in registry data.
Quick answer
NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.
Top sponsors
- Chinese Academy of 207 programs
- First People's Hospital 186 programs
- Takeda 154 programs
- United Therapeutics Europe 121 programs
- BRIGHT MINDS BIOSCIENCES 116 programs
- Disc Medicine 103 programs
- George Institute for 83 programs
- Hospital Authority 60 programs
- Regeneron UK 60 programs
- Sinovac Research and 47 programs
- Teva Pharma 39 programs
- Pacira Ireland 36 programs
Pipeline programs
-
Intravenous thrombolysis + edaravone
The First People's Hospital of Lianyungang
Ischemic Stroke
1 trial -
Intravenous/Subcutaneous Treprostinil; Oral Treprostinil
United Therapeutics Europe Ltd
Pulmonary Arterial Hypertension
1 trial -
Intravitreal Aflibercept
Regeneron UK Limited
Diabetic Macular Edema
2 trials -
Intravitreal Aflibercept Injection
Regeneron UK Limited
Cystoid Macular Edema
1 trial -
Intravitreal Aflibercept Injection (IAI)
Regeneron UK Limited
Chorioretinal Vascular Disease
1 trial -
Intravitreal Aflibercept Injection (IAI)
Regeneron UK Limited
Age - Related Macular Degeneration (AMD)
1 trial -
Intravitreal Aflibercept Injection 2mg
Regeneron UK Limited
Neovascular Age-related Macular Degeneration
2 trials -
Intravitreal aflibercept injection
Regeneron UK Limited
Macular Degeneration
1 trial -
Intravitreal aflibercept injection 2.0mg
Regeneron UK Limited
Polypoidal Choroidal Vasculopathy
1 trial -
Investigational 23-valent PPV
Sinovac Research and Development Co.,
Pneumococcal Infections
2 trials -
Investigational live attenuated varicella vaccine
Sinovac Research and Development Co.,
Varicella
4 trials -
Iomeron 400 mgI/ml solution for injection
The George Institute
Thoracic neoplasm
1 trial -
Irinotecan liposomes combined with cisplatin/carboplatin
The First People's Hospital of Lianyungang
Neuroendocrine Tumors
1 trial -
Isoniazid
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Tuberculosis, Pulmonary
1 trial -
Isoniazid
United Therapeutics Europe Ltd
Tuberculosis
2 trials -
Isoniazid Aminosalicylate Tablets
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Reinfection Pulmonary Tuberculosis
1 trial -
Isotonic hydration fluid and recombinant human hyaluronidase
HALOZYME THERAPEUTICS, INC.
Dehydration
1 trial -
Isotretinoin
VYNE Therapeutics
Acne Vulgaris
1 trial -
Ivabradine + Usual Care
The University of Hong Kong
Atrial Fibrillation (Permanent)
1 trial -
Ixazomib
The First People's Hospital of Lianyungang
Multiple Myeloma
1 trial -
Ixazomib
Takeda
Relapsed and/or Refractory Multiple Myeloma
4 trials -
Ixekizumab
Hospital Authority, Hong Kong
Plaque Psoriasis
1 trial -
JAK Inhibitor
The First People's Hospital of Lianyungang
Dermatomyositis, Adult Type
1 trial -
JZP-258
Jazz Pharmaceuticals Ireland Limited
Narcolepsy
1 trial -
JZP258
Jazz Pharmaceuticals Ireland Limited
Narcolepsy
1 trial -
JZP258 (XYWAV)
Jazz Pharmaceuticals Ireland Limited
Idiopathic Hypersomnia
1 trial -
Jejunostomy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastric Cancer
1 trial -
K9520
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Multiple Myeloma
1 trial -
KANG FU PEN
The First People's Hospital of Lianyungang
Cervical Cancer
1 trial -
KCHRF-DASH-AF-0002
Rhythm Pharmaceuticals Netherlands B.V.
Arrhythmias, Cardiac
1 trial -
KCT02/2023-SATELLITE
Novo Nordisk A/S
Arterial hypertension
1 trial -
KCT10/2022-LEASH
Novo Nordisk A/S
Hyperlipidaemia
1 trial -
KCT23/2022-ZOOM-IN
Novo Nordisk A/S
Knee osteoarthritis
1 trial -
KTI2023
The George Institute
Graft pyelonephritis in kidney transplant recipients
1 trial -
Kanglaite Injection+Chemotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
NSCLC
1 trial -
Kesimpta 20 mg solution for injection in pre-filled syringe
Novartis Pharmaceuticals
Relapsing forms of Multiple Sclerosis (RMS)
1 trial -
Ketamine
United Therapeutics Europe Ltd
Chronic Postoperative Pain
1 trial -
Ketamine
Teva Pharma GmbH
Treatment Resistant Depression
1 trial -
Ketamine Hydrochloride
NORTHWEST BIOTHERAPEUTICS INC
Revision Spine Surgery
1 trial -
Ketamine Hydrochloride
United Therapeutics Europe Ltd
Hemorrhage
1 trial -
Ketorolac Injection
United Therapeutics Europe Ltd
Orthopaedic Trauma
1 trial -
Keverprazan
The First People's Hospital of Lianyungang
H. Pylori Infection
1 trial -
Kineret 100 mg/0.67 ml solution for injection in pre-filled syringe.
Disc Medicine
autoimmune disorders, joint disorders synonym: Still's disease, systemic JIA
1 trial -
Klisyri 10 mg/g ointment, Solaraze 30 mg/g Gel
Almirall, S.A.
Actinic Keratosis
1 trial -
Kuvan
BioMarin Pharmaceutical Australia Pty Ltd
Phenylketonuria (PKU)
2 trials -
Kuvan®
BioMarin Pharmaceutical Australia Pty Ltd
Phenylketonuria
2 trials -
L. helveticus R0052 and B. longum R0175
Acadia Pharmaceuticals B.V.
Attention Deficit Hyperactivity Disorder
1 trial -
LABA/LAMA or Placebo inhalation
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Bronchiectasis Adult
1 trial
Frequently asked questions
How many Approved programs pipeline programs are in the directory?
1,839 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.